Jingqin Zhong

Shanghai, 201315, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma.

Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma.

Journal: Journal of translational medicine

Published: June 15, 2025

Gene Fusions as Potential Therapeutic Targets in Soft Tissue Sarcomas.

Gene Fusions as Potential Therapeutic Targets in Soft Tissue Sarcomas.

Journal: Biomolecules

Published: May 19, 2025

RAC2 drives hypoxia-mediated radiation resistance in nasopharyngeal carcinoma.

RAC2 drives hypoxia-mediated radiation resistance in nasopharyngeal carcinoma.

Journal: Biochemical and biophysical research communications

Published: April 17, 2025

PD-1 blockade treatment in melanoma: Mechanism of response and tumor-intrinsic resistance.

PD-1 blockade treatment in melanoma: Mechanism of response and tumor-intrinsic resistance.

Journal: Cancer science

Published: May 29, 2024

The Role of CDCA2 in tumor genesis, prognosis and future treatments.

The Role of CDCA2 in tumor genesis, prognosis and future treatments.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 19, 2024

An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma.

An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma.

Journal: Theranostics

Published: October 28, 2023

Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.

Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.

Journal: Clinical and experimental medicine

Published: May 03, 2023

Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses.

Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses.

Journal: Nature communications

Published: April 11, 2023

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies.

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies.

Journal: Current treatment options in oncology

Published: December 02, 2022

Comparative analysis of adjuvant therapy for stage III BRAF-mut melanoma: A real-world retrospective study from single center in China.

Comparative analysis of adjuvant therapy for stage III BRAF-mut melanoma: A real-world retrospective study from single center in China.

Journal: Cancer medicine

Published: October 18, 2022

CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.

CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 29, 2022

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies.

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies.

Journal: Current treatment options in oncology

Published: July 27, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026